JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.
Zhang Y, Xia F, Liu X, Yu Z, Xie L, Liu L, Chen C, Jiang H, Hao X, He X, Zhang F, Gu H, Zhu J, Bai H, Zhang CC, Chen GQ, Zheng J.
Zhang Y, et al. Among authors: bai h.
J Clin Invest. 2018 May 1;128(5):1737-1751. doi: 10.1172/JCI93198. Epub 2018 Mar 26.
J Clin Invest. 2018.
PMID: 29584620
Free PMC article.